The company criticized for hiking the price of EpiPens by more than 400% in the past decade announced measures on Thursday to reduce the price for some individuals.
Mylan pharmaceuticals will offer a discount of up to $300 for patients whose health plans require “higher out-of-pocket costs.” This could cut the costs in half for some patients, according to a press release. The company will also expand access to a program that provides epipens to uninsured patients.
“We recognize the significant burden on patients from continued, rising insurance premiums,” said Mylan CEO Heather Bresch in the release. “Patients deserve increased price transparency and affordable care.”
Politicians on both sides of the aisle have criticized the rapid price increase for the medical devices in recent weeks, including Democratic presidential candidate Hillary Clinton.
The Leadership Brief. Conversations with the most influential leaders in business and tech.
